Penile trabecular smooth muscle tone, a major determinant of erectile function, is highly regulated by numerous inter-and intracellular pathways. The interaction between pathways mediating contraction and relaxation has not been studied in detail. To this end, we investigated the functional effects of alpha adrenergic receptor blockade with phentolamine and its interaction with vasodilators (sildena®l, vasoactive intestinal polypeptide (VIP) and PGE1) that elevate cyclic nucleotides on penile cavernosal smooth muscle contractility. In organ bath preparations of cavernosal tissue strips contracted with phenylephrine, phentolamine signi®cantly enhanced relaxation induced by sildena®l, VIP and PGE1. Sildena®l, VIP or PGE1 also signi®cantly enhanced relaxation induced by phentolamine in cavernosal tissue strips contracted with phenylephrine. To study the effects of alpha adrenergic receptor blockade and modi®cation of cyclic nucleotide metabolism during active neurogenic input, cavernosal tissue strips in organ bath preparations were contracted with the non-adrenergic agonist endothelin-1 and subjected to electrical ®eld stimulation (EFS) in the absence or presence of phentolamine andaor sildena®l. EFS (5±40 Hz) typically caused biphasic relaxation and contraction responses. Phentolamine alone enhanced relaxation and reduced or prevented contraction to EFS. Sildena®l enhanced relaxation to EFS at lower frequencies ( 5 Hz). The combination of phentolamine and sildena®l enhanced EFS-induced relaxation at all frequencies tested. EFS, in the presence of 10 nM phentolamine and 30 nM sildena®l, produced enhanced relaxation responses which were quantitatively similar to those obtained in the presence of 50 nM sildena®l alone. Thus, blockade of a a-adrenergic receptors with phentolamine increases the ef®cacy of cyclic nucleotide-dependent vasodilators. Furthermore, phentolamine potentiates relaxation and attenuates contraction in response to endogenous neurotransmitters which are released during EFS. These ®ndings suggest that antagonism of aadrenergic signaling enables other independent relaxatory pathways to predominate within penile trabecular smooth muscle.
Introduction
The signaling pathways stimulated by alpha adrenergic receptors and intracellular cyclic nucleotides (cAMP and cGMP) are important regulators of penile cavernosal smooth muscle tone. Contraction of corpus cavernosum trabecular smooth muscle to catecholamines is mediated by post-junctional alpha-1 and alpha-2 adrenergic receptors. 1±7 The binding of catecholamines to alpha-1 adrenergic receptors stimulates interaction with G qa11 protein, causing the activation of phospholipase C b1 and subsequent production of IP 3 and diacylglycerol. 8, 9 Alpha-2 adrenergic receptors inhibit adenylate cyclase activity via G i protein and have also been shown to modulate calcium in¯ux either by Gprotein coupled or G-protein independent mechanisms. 8±10 These receptors are also implicated in the activation of phospholipase C, phospholipase D, potassium channels and Na aH exchange. 10 These alpha-adrenergic receptor-mediated events result in elevated intracellular calcium or increased calcium sensitivity and ultimately enhance actin-myosin cross-bridge cycling to increase smooth muscle tone. Thus, alpha-adrenergic receptors are crucial in the process of detumescence and may be important in maintaining penile¯accidity.
11±14
Multiple receptor systems activate cyclic nucleotide-mediated relaxation. In addition to the direct activation of guanylate cyclase by nitric oxide, 15 two agonists (among others) which stimulate cAMP production in penile trabecular smooth muscle are prostaglandin E1 (PGE1) and vasoactive intestinal polypeptide (VIP).
14 EP receptors mediate the cellular response to PGE1 and are categorized into four pharmacologic subclasses (EP 1 ±EP 4 ), with isoform variants in each subclass which may arise from alternative splicing of a single gene product. 16±19 VIP, EP 2 , EP 3II and EP 4 receptors mediate smooth muscle relaxation by coupling to G s protein and stimulating adenylate cyclase to increase intracellular cAMP. 14Y 18 À 23 In the clinical setting, systemic administration of alpha-adrenergic antagonists facilitates penile erection and has been associated with prolonged erection or priapism.
11±14,24±28 In addition, orally administered doxazosin, an alpha-adrenergic receptor antagonist, has been reported to increase the ef®cacy of intracavernosal vasodilator therapy with alprostadil (PGE1) in men with moderate to severe erectile dysfunction. 29 While it may be postulated that the relative predominance of any of the regulatory mechanisms could favor penile tumescence or detumescence, the interaction between contractile and relaxatory pathways has not been studied in detail. Thus, the objective of this study was to investigate the functional effects of alpha-adrenergic receptor blockade and its interaction with vasodilators (sildena®l, VIP and PGE1) that elevate cyclic nucleotides on penile corpus cavernosum smooth muscle contractility.
Methods

Tissue procurement
All protocols for studies involving human and rabbit tissues were approved by the Institutional Review Board for Human Studies and the Institutional Animal Care and Use Committee at Boston University School of Medicine. Human penile corpus cavernosum tissue was obtained from patients diagnosed with erectile dysfunction and undergoing penile prosthesis implantation. Cavernosal biopsies were transported to the research laboratory in icecold physiological salt solution (PSS; 118.3 mM NaCl, 4.7 mM KCl, 0.6 mM MgSO 4 , 1.2 mM KH 2 PO 4 , 2.5 mM CaCl 2 , 25 mM NaHCO 3 , 0.026 mM CaNa 2 EDTA, 11.1 mM glucose) for immediate study and cut into strips (3 6 3 6 10 mm) for use in organ bath experiments. Rabbit corpus cavernosum tissue was obtained from euthanized male New Zealand White rabbits (3.0±3.5 kg body weight), as previously described. 30 Cavernosal tissue from each rabbit was cut into four strips for organ bath experiments.
Measurement of changes in isometric tension
Human and rabbit cavernosal tissues were mounted onto force transducers (Model FT03; Grass Instruments, Quincy, MA) and immersed in 25 ml baths of PSS at 37 C which were aerated with 5% CO 2 , 19% O 2 , 76% N 2 . Tissues were treated with 3 mM indomethacin and progressively stretched until optimal isometric tension was reached, as described previously. 30 Tissues were then subjected to one of several experimental protocols, as outlined below. All protocols included 3 mM indomethacin to inhibit prostanoid production.
Dose responses
Cavernosal tissue strips in organ bath preparations were contracted with 1 mM phenylephrine or 40 nM endothelin-1 as speci®ed in the results section. Tissues were incubated with vehicle or 5±50 nM phentolamine mesylate (Research Biochemicals, Inc., Natick, MA) for 20 min and then exposed to increasing concentrations of sildena®l citrate (P®zer Ltd., Sandwich, Kent, UK), vasoactive intestinal polypeptide (VIP; Peninsula Laboratories, San Carlos, CA) or prostaglandin E1 (PGE1; Cayman Chemical Co., Ann Arbor, MI). In parallel experiments, cavernosal tissue strips were contracted with 1 mM phenylephrine or 40 nM endothelin-1, incubated with sildena®l (0±20 nM), VIP (0±100 nM) or PGE1 (0±500 nM) and exposed to increasing concentrations of phentolamine.
Electrical ®eld stimulation
Cavernosal tissue strips in organ bath preparations were contracted with 40 nM endothelin-l and subjected to electrical ®eld stimulation. As described previously, 30 EFS was accomplished by means of two platinum plate electrodes, positioned on either side of the tissue and a current ampli®er in series with a square pulse stimulator (Model SD9; Grass Instruments, Quincy, MA). An oscilloscope was used to monitor stimulation parameters. Each stimulation period lasted 20 s with trains of square waves having a pulse duration of 0.5 ms, and a potential difference of 10 V. Frequency was varied from 0.5 to 40 Hz. Electrical stimulation with these parameters elicits tetrodotoxin sensitive responses in corpus cavernosum, indicating a speci®c nervemediated action. 31 In some experiments, tissue strips were treated with 1 mM atropine and 10 mM bretylium to isolate non-adrenergic, non-cholinergic responses. After the initial set of stimulations, tissues were treated with phentolamine alone, sildena®l alone or a combination of phentolamine and sildena®l at the indicated concentrations. After stable tone was achieved, electrical stimulations were repeated.
Analysis of data
At the end of each experiment, all tissue strips were treated with 10 mM papaverine and 10 mM nitroprusside to induce maximal relaxation (100%). For dose responses, the`relaxation index' was determined by crude integration of the area over the relaxation curve. The relaxation index of a given dose response obtained in treated tissue was compared to that obtained in untreated (control) tissue by t-test. EC 50 values were estimated by constructing pseudo-Hill plots. Using the equation describing the line of linear regression, we determined the concentration of drug (x) at which log[Ra(R max 7 R)] 0 (y); where R percent of maximal relaxation response and R max maximal relaxation (i.e. 100%). For electrical ®eld stimulation studies, the response at each frequency of stimulation in the presence of drug was compared to control responses using paired ttest. Responses were further analyzed by determining the ratios of the responses in the presence and absence of drug treatment and comparing these ratios with those of the time control. For all t-tests (paired and unpaired), comparisons were deemed to be statistically signi®cant if the two-tailed P-value was less than or equal to 0.05 (indicated by an asterisk).
Results
Effect of phentolamine on the ef®cacy of sildena®l, VIP or PGE1
Relaxation dose responses to sildena®l, VIP or PGE1 were performed in the absence or presence of phentolamine in rabbit and human penile cavernosal tissue strips. In tissue strips contracted with 1 mM phenylephrine, addition of a single concentration of phentolamine caused a sustained relaxation. At all concentrations tested, phentolamine enhanced relaxation to sildena®l, although concentrations above 10 nM did not cause further improvement ( Figure 1A and Table 1 ). When the data were normalized to account for the initial relaxation caused by phentolamine treatment prior to sildena®l exposure, this potentiation did not persist ( Figure 2A ). As shown in Table 1 , in tissues contracted with the non-adrenergic vasoconstrictor endothelin-1, phentolamine (5±20 nM) caused a slight relaxation. However, no signi®cant potentiation of sildena®l-induced relaxation was observed at any concentration of phentolamine tested. As indicated in Table 1 , EC 50 values and relaxation indices were not signi®cantly altered with phentolamine treatment.
Since the effects of VIP are readily reversed by extensive washing, the control response was obtained ®rst for each tissue strip and the response was then repeated in the presence of phentolamine. In this set of experiments, VIP caused relaxation in phenylephrine-contracted cavernosal tissue strips with varying ef®cacy. In the absence of phentolamine, relaxation responses in rabbit cavernosal tissue exhibited greater consistency with a mean EC 50 value of 56 nM. EC 50 values for control responses in human cavernosal tissue varied from 48.5 to 214.7 nM (Table 2) . Subsequent VIP dose responses in the presence of vehicle were not signi®cantly different from the initial responses, indicating that repeated exposure to VIP alone did not alter the sensitivity of the tissue. In both rabbit and human tissues treated with phentolamine, VIP responses were progressively potentiated, relative to the dose of phentolamine which was used (Table 2 and Figure 1B ). In addition, phentolamine caused a larger enhancement of VIP-induced relaxation in Figure 1 Effect of phentolamine on vasodilator-induced relaxation. Organ bath preparations of rabbit and human penile cavernosal tissue strips were contracted with 1 mM phenylephrine and treated with vehicle (control) or phentolamine (PA) at the indicated concentrations. Tissue strips were then exposed to increasing concentrations of sildena®l (A), VIP (B) or prostaglandin E1 (C). human tissue, relative to the rabbit. Unlike sildena®l, signi®cant differences between VIP-induced relaxation in the absence and presence of 40 nM phentolamine persisted even when the data were normalized to account for the initial relaxation caused by phentolamine treatment prior to VIP exposure ( Figure 2B ).
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Similar to VIP, PGE1-induced relaxation was signi®cantly enhanced in a dose-dependent manner by the addition of 10±50 nM phentolamine (Table 3 and Figure 1C) . Phentolamine, at 50 nM, enhanced PGE1-mediated relaxation by approximately 50-fold. This potentiation also persisted (although to a lesser degree) after the data were normalized to account for Phentolamine and vasodilators NN Kim et al the effect of phentolamine before addition of PGE1 ( Figure 2C ). Dose responses to PGE1 were performed only in human cavernosal tissue because rabbit penile corpus cavernosum responds poorly to relaxatory prostanoids.
Effect of sildena®l, VIP and PGE1 on phentolamineinduced relaxation
To further study the interaction of adrenergic receptor antagonism and cyclic nucleotide-mediated smooth muscle relaxation, we performed dose responses to phentolamine in the absence or presence of sildena®l, VIP or PGE1. These vasodilators were used at concentrations which produced mild to moderate trabecular smooth muscle relaxation. On average, sildena®l (5±20 nM) enhanced relaxation to phentolamine by 1.4-fold and decreased the EC 50 of phentolamine by a factor of 15 (Table 4 and Figure 3A ). Higher concentrations of sildena®l did not signi®cantly increase the potentiation observed at 5 nM. When the data were normalized to account for the initial relaxation caused by sildena®l treatment prior to phentolamine exposure ( Figure 4A ), the potentiation did not persist. VIP and PGE1 also enhanced relaxation to phentolamine (Table 4 and Figure 3 ). The enhancement by VIP was somewhat less than the potentiation by sildena®l and also did not persist when the data were normalized to account for the initial relaxation produced by VIP prior to the addition of phentolamine ( Figure 4B ). Responses to PGE1 were variable in human corpus cavernosum tissue obtained from different patients. Treatment with 50 or 500 nM PGE1 elicited relaxation ranging from 0 to 60% of the maximal response. Nevertheless, signi®cant enhancement was observed when phentolamine dose responses were performed in the presence of PGE1. Interestingly, this potentiation occurred even though the average relaxation response to PGE1 was minimal ( Figure 3C) . Thus, the enhancement persisted after normalization of the data ( Figure 4C ).
Electrical ®eld stimulation studies
Penile cavemosal tissue was subjected to EFS at varying frequencies to cause the release of endogenous neurotransmitters. This protocol enabled us to study the effects of adrenergic receptor blockade and modi®cation of cyclic nucleotide metabolism during active neurogenic input without the complications of systemic factors that may arise from in vivo experimental models. In addition to phentolamine, the mechanism of action of sildena®l enabled us to examine the functional interaction between adrenergic receptor-mediated contraction and cGMPmediated relaxation. The exogenous agonists VIP and PGE1 were not studied in this paradigm. All tissue strips were contracted with endothelin-1 (40 nM) to exclude exogenous adrenergic stimulation. In the absence of vasoactive modi®ers, EFS elicited characteristic biphasic responses consisting of a primary relaxation, followed by a contraction. Contractile responses became more prevalent and relaxatory responses decreased as a function of increasing frequency (Figures 5 and 7) . Immediately after EFS was terminated, tissues sometimes exhib- Phentolamine (10±20 nM) potentiated the EFSinduced primary relaxation above and beyond the time control at all frequencies tested (Figures 6 and  7) . Additionally, the contractile responses were consistently attenuated in the presence of 20 nM phentolamine, reversing the trend of increased contraction at high frequencies ( ! 15 Hz) in the control (Figures 5 and 7) . Sildena®l also potentiated EFS-induced relaxation to a greater degree than the time control, although the effect was more pronounced at lower frequencies ( 5 Hz; data not shown). The responses to EFS with the combined treatment of phentolamine and sildena®l enhanced relaxation in a dose dependent manner to a greater degree than the time control at all frequencies ( Figure 8 ). Furthermore, primary relaxation responses with a combination of 10 nM phentolamine and 30 nM sildena®l were quantitatively similar to the responses obtained in the presence of 50 nM sildena®l alone.
When NANC relaxation responses were isolated by treatment with bretylium and atropine, sildena®l caused an enhancement of EFS-induced NANC 
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NN Kim et al relaxation at frequencies ! 2 Hz whereas phentolamine did not change the responses, relative to the time control (data not shown). The combination of phentolamine and sildena®l produced responses that were similar to sildena®l alone.
Discussion
Our results indicate that blockade of alpha-adrenergic receptors with phentolamine increases the ef®cacy of sildena®l, VIP or PGE1 to induce smooth muscle relaxation. These vasodilators also enhanced phentolamine-induced relaxation. Since phentolamine and cyclic nucleotide-dependent vasodilators cause relaxation by different intracellular mechanisms, enhanced relaxation may be attributed to either additive or synergistic effects. We attempted to differentiate these two types of interactions by subtracting the initial effect of a given drug prior to the addition of the second compound. After this type of normalization analysis was performed, the enhancement by phentolamine persisted for VIP and PGE1-induced relaxation but not for sildena®l-induced relaxation. This suggests a potential synergistic interaction between antagonism of alpha-adrenergic signaling and cAMP-mediated relaxation, whereas the interaction between phentolamine and cGMP-mediated relaxation appears to be additive.
In examining the effect of sildena®l, VIP or PGE1 on phentolamine-induced relaxation, normalization of dose response data led to similar conclusions for sildena®l (additive effect) and PGE1 (synergistic effect), but not for VIP. Phentolamine-induced relaxation was enhanced by VIP, but this potentiation did not persist when the data were normalized. This disparity between the effect of VIP on phentolamine-induced relaxation versus the effect of phentolamine on VIP-induced relaxation may be due, in part, to the relative predominance of the two different receptor-mediated signalling pathways. Blockade of alpha-adrenergic receptor-mediated contraction by phentolamine may be more effective in facilitating relaxation than VIP in penile trabecular smooth muscle. If this were the case, phentolamine-induced relaxation would overcome any slight synergism produced by the addition of VIP. It is interesting to note that phentolamine enhancement of the VIP response was greater in penile cavernosal tissue from men with erectile dysfunction than in penile cavernosal tissue from healthy rabbits. It is unclear if this difference arises from species variation or from compromised sensitivity to VIP, associated with erectile dysfunction. Differences may also exist between EP and VIP receptormediated stimulation of adenylate cyclase, 32 but Phentolamine and vasodilators NN Kim et al characterization of these interactions requires further investigation. Thus, our data are consistent with the hypothesis that the alpha adrenergic signalling pathway interacts directly with the cAMP pathway but is largely independent of the nitric oxide pathway. Since both subtypes of alpha adrenergic receptors are present on the surface of penile trabecular smooth muscle cells, 5±7 post-junctional alpha-2 adrenergic receptors are the most likely mediators of the interaction with the cAMP pathway. Alpha-2 adrenergic receptors have been shown to inhibit cAMP-mediated responses in many different systems. In cultured human and rabbit corpus cavernosum smooth muscle cells, PGE1 and forskolin-induced cAMP synthesis was inhibited by the alpha-2 adrenergic receptor agonist UK14304. 6, 20 Accumulation of cAMP is inhibited by alpha-2 adrenergic receptor agonists in brain, adipose and retinal tissue. 33 À 35 In the rat jejunum, stimulation of alpha-2 adrenergic receptors antagonizes the effects of PGE1 and VIP on intestinal¯uid secretion. 36 Cyclic AMP-mediated insulin release from pancreatic islet cells is also inhibited by alpha-2 adrenergic receptor agonists. 37 In the penile corpus cavernosum, phentolamine antagonizes norepinephrine binding and may relieve the inhibition of cAMP synthesis by alpha-2 adrenergic receptors.
While evaluating cavernosal tissue responses to exogenous vasodilators are informative, the interaction between alpha adrenergic blockade and vasodilators may be further characterized by examining neurogenic responses in penile corpus cavernosum tissue strips. This experimental paradigm enabled us to study the action of phentolamine on endogenous vasoactive substances which are released during electrical stimulation. Since tissue strips were contracted with endothelin-1, a non-adrenergic vasoconstrictor which is not directly antagonized by phentolamine, the only source of adrenergic input was norepinephrine released from nerve endings in the cavernosal tissue during electrical stimulation. We observed that phentolamine modi®ed the biphasic response to electrical stimulation by potentiating relaxation and attenuating contraction. These ®ndings suggest that antagonism of alpha-adrenergic neurogenic input enables other independent relaxatory pathways to predominate within penile trabecular smooth muscle. In addition to nitric oxide, it is likely that VIP is also released as a relaxatory co-transmitter. The release of prostaglandin E during electrical stimulation of isolated cavernosal tissue strips has not been reported. However, in the intact penis, increased blood¯ow and tissue oxygenation, secondary to NANC neurotransmitter release, may stimulate the production and release of prostanoids from endothelial and smooth muscle cells. 38±40 The involvement of other relaxatory neurotransmitters or paracrineaautocrine substances remains to be de®ned.
The sequence of responses during electrical stimulation provide some insight into the integrated regulation of cavernosal smooth muscle tone. An initial transient`primary relaxation' is observed immediately after onset of the electrical stimulus. This is followed by the contractile response which persists during the course of the stimulation and immediately ceases upon termination of EFS. Typically, cavernosal tissue strips exhibit a`secondary relaxation' following the termination of EFS. It is likely that multiple factors mediate this prolonged relaxation. The ability of the contractile response to overcome the initial relaxation suggests that the effect of adrenergic nerves predominates over that of relaxatory non-adrenergic, non-cholinergic nerves. Rapid inactivation of the relaxatory response during stimulation is unlikely since all nerve endings within the tissue are stimulated indiscriminantly. Furthermore, when cavernosal tissue strips are treated with inhibitors of adrenergic neurotransmission, only relaxatory responses are observed during the full course of electrical stimulation. 30, 31 The dependence of the contractile response on active stimulation and the presence of the slower secondary relaxation' in the absence of active stimulation suggests that the relaxatory response is longer lasting and is`unmasked' when adrenergic input ceases. Thus, phentolamine, at suf®cient concentrations, should attenuate the adrenergic input and decrease the`resistance' to relaxation. In this manner, phentolamine may potentiate the primary relaxation and be more effective at higher frequencies of stimulation where adrenergic input is greater. Sildena®l alone also enhanced the primary relaxation, presumably by stabilizing intracellular cGMP synthesized in response to nitric oxide. The combined treatment of phentolamine and a lower dose of sildena®l produced similar relaxation to a higher dose of sildena®l alone. For instance, the relaxation response to EFS with a combination of 10 nM phentolamine and 30 nM sildena®l was similar to that obtained with 50 nM sildena®l alone.
In the presence of adrenergic and cholinergic blockade, the contractile response in cavernosal tissue strips is abolished and only relaxation is observed during electrical stimulation. Thus, if phentolamine enhances relaxation by attenuating contraction mediated by alpha adrenergic receptors, one would expect to observe no effect by a pure adrenergic antagonist on isolated NANC responses. Indeed, phentolamine did not signi®cantly enhance EFS-induced NANC relaxation relative to the time control. In contrast, sildena®l remained ef®cacious in potentiating EFS-induced NANC relaxation. This is not surprising, since the nitric oxide pathway predominates in the mediation of NANC relaxation.
14 A secondary mechanism of action has also been reported for phentolamine. In addition to the direct antagonism of catecholamine action on alpha-1 and alpha-2 adrenergic receptors, phentolamine may act on the endothelium to stimulate nitric oxide synthase or increase the ef®cacy of nitric oxide released from the endothelium. 41 This effect was not apparent in the present study and the signi®cance of this alternative pathway remains unclear.
In summary, we observe enhancement of penile cavernosal smooth muscle relaxation with phentolamine only when adrenergic input is present. While other constrictive factors such as endothelins and prostanoids may be important in maintaining¯ac-cidity, it is reasonable to assume that adrenergic tone may also predominate over relaxatory mechanisms in the¯accid state of the penis. Thus, phentolamine could reduce the predominance of the contractile pathway and the`resistance to relaxation' (see Figure 9 ). This may prove to be important in cases where basal adrenergic tone is greater than normal. The responsiveness of human erectile tissue to alpha adrenergic agonists is thought to be altered by age and disease and the ef®cacy of phenylephrine-induced contraction is signi®cantly increased in cavernosal tissue from impotent men. 42±44 Thus, it is possible that adrenergic imbalance towards vasoconstriction impairs erection. This mechanism of action may substantiate the use of phentolamine as an adjunct therapy for erectile dysfunction when used in combination with other drugs which initiate vasodilation through different mechanisms.
